Debiopharm Academy - Discover the pharma world 3.0
Event details
| Date | 27.02.2014 |
| Hour | 18:30 › 20:30 |
| Speaker |
Andrés McAllister M.D., Ph.D. - Chief Scientific Officer - Research & Evaluation, Debiopharm International Stewart T. Cole Ph.D., FRS - Professor, Director of the Global Health Institute, EPFL |
| Location | |
| Category | Conferences - Seminars |
Developing new antibiotics: the big challenge in 2014
One of the major scientific accomplishments of modern medicine has been the development of antibiotics and the control of once devastating infectious diseases. Infections that were once lethal became diseases that could simply be cured by a short course of antibiotics. Unfortunately, this major achievement led to the indiscriminate use of the new agents which in turn put a strong pressure on microorganisms to generate new mechanisms of resistance to the new drugs. The plasticity and ever-changing nature of the microbes is now turning into a continuous increase in resistance to available medicines. Diseases which were once easily treated can be again life-threatening. Read more...
One of the major scientific accomplishments of modern medicine has been the development of antibiotics and the control of once devastating infectious diseases. Infections that were once lethal became diseases that could simply be cured by a short course of antibiotics. Unfortunately, this major achievement led to the indiscriminate use of the new agents which in turn put a strong pressure on microorganisms to generate new mechanisms of resistance to the new drugs. The plasticity and ever-changing nature of the microbes is now turning into a continuous increase in resistance to available medicines. Diseases which were once easily treated can be again life-threatening. Read more...
Links
Practical information
- General public
- Registration required
Organizer
- Debiopharm International & EPFL Alumni
Contact
- Aurelie Schick